Cargando…
Structural re-positioning, in silico molecular modelling, oxidative degradation, and biological screening of linagliptin as adenosine 3 receptor (ADORA3) modulators targeting hepatocellular carcinoma
Chemical entities with structural diversity were introduced as candidates targeting adenosine receptor with different clinical activities, containing 3,7-dihydro-1H-purine-2,6-dione, especially adenosine 3 receptors (ADORA3). Our initial approach started with pharmacophore screening of ADORA3 modula...
Autores principales: | Ayoub, Bassam M., Attia, Yasmeen M., Ahmed, Mahmoud S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010121/ https://www.ncbi.nlm.nih.gov/pubmed/29768061 http://dx.doi.org/10.1080/14756366.2018.1462801 |
Ejemplares similares
-
Alternative adenosine Receptor activation: The netrin-Adora2b link
por: Yuan, Xiaoyi, et al.
Publicado: (2022) -
Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride using High Performance Liquid Chromatography
por: El-Bagary, Ramzia I., et al.
Publicado: (2013) -
ADORA2A variation and adenosine A(1) receptor availability in the human brain with a focus on anxiety-related brain regions: modulation by ADORA1 variation
por: Hohoff, Christa, et al.
Publicado: (2020) -
Liquid Chromatographic Determination of Linagliptin in Bulk, in Plasma and in its Pharmaceutical Preparation
por: El-Bagary, Ramzia I., et al.
Publicado: (2012) -
ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)